REL_HUMAN - dbPTM
REL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID REL_HUMAN
UniProt AC Q04864
Protein Name Proto-oncogene c-Rel
Gene Name REL
Organism Homo sapiens (Human).
Sequence Length 619
Subcellular Localization Nucleus.
Protein Description Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The NF-kappa-B heterodimer RELA/p65-c-Rel is a transcriptional activator..
Protein Sequence MASGAYNPYIEIIEQPRQRGMRFRYKCEGRSAGSIPGEHSTDNNRTYPSIQIMNYYGKGKVRITLVTKNDPYKPHPHDLVGKDCRDGYYEAEFGQERRPLFFQNLGIRCVKKKEVKEAIITRIKAGINPFNVPEKQLNDIEDCDLNVVRLCFQVFLPDEHGNLTTALPPVVSNPIYDNRAPNTAELRICRVNKNCGSVRGGDEIFLLCDKVQKDDIEVRFVLNDWEAKGIFSQADVHRQVAIVFKTPPYCKAITEPVTVKMQLRRPSDQEVSESMDFRYLPDEKDTYGNKAKKQKTTLLFQKLCQDHVETGFRHVDQDGLELLTSGDPPTLASQSAGITVNFPERPRPGLLGSIGEGRYFKKEPNLFSHDAVVREMPTGVSSQAESYYPSPGPISSGLSHHASMAPLPSSSWSSVAHPTPRSGNTNPLSSFSTRTLPSNSQGIPPFLRIPVGNDLNASNACIYNNADDIVGMEASSMPSADLYGISDPNMLSNCSVNMMTTSSDSMGETDNPRLLSMNLENPSCNSVLDPRDLRQLHQMSSSSMSAGANSNTTVFVSQSDAFEGSDFSCADNSMINESGPSNSTNPNSHGFVQDSQYSGIGSMQNEQLSDSFPYEFFQV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MASGAYNPY
------CCCCCCCCC
19.3722814378
3Phosphorylation-----MASGAYNPYI
-----CCCCCCCCCE
23.7423186163
6Phosphorylation--MASGAYNPYIEII
--CCCCCCCCCEEEE
21.8624719451
26SumoylationRGMRFRYKCEGRSAG
CCCCEEEEECCCCCC
22.89-
26SumoylationRGMRFRYKCEGRSAG
CCCCEEEEECCCCCC
22.89-
31PhosphorylationRYKCEGRSAGSIPGE
EEEECCCCCCCCCCC
48.0820873877
34PhosphorylationCEGRSAGSIPGEHST
ECCCCCCCCCCCCCC
25.9024719451
46PhosphorylationHSTDNNRTYPSIQIM
CCCCCCCCCCEEEEE
41.7429507054
47PhosphorylationSTDNNRTYPSIQIMN
CCCCCCCCCEEEEEE
7.5524043423
49PhosphorylationDNNRTYPSIQIMNYY
CCCCCCCEEEEEEEE
19.4024043423
55PhosphorylationPSIQIMNYYGKGKVR
CEEEEEEEECCCEEE
9.0124043423
56PhosphorylationSIQIMNYYGKGKVRI
EEEEEEEECCCEEEE
13.8324043423
68AcetylationVRITLVTKNDPYKPH
EEEEEEECCCCCCCC
52.4525953088
82UbiquitinationHPHDLVGKDCRDGYY
CCCCCCCCCCCCCCE
46.2929967540
88PhosphorylationGKDCRDGYYEAEFGQ
CCCCCCCCEECCCCC
11.4722817900
89PhosphorylationKDCRDGYYEAEFGQE
CCCCCCCEECCCCCC
17.7522817900
176PhosphorylationPVVSNPIYDNRAPNT
CCCCCCCCCCCCCCC
14.3928064214
210UbiquitinationEIFLLCDKVQKDDIE
EEEEEECCCCCCCCE
45.6429967540
210AcetylationEIFLLCDKVQKDDIE
EEEEEECCCCCCCCE
45.6425953088
254O-linked_GlycosylationPPYCKAITEPVTVKM
CCCCCCCCCCEEEEE
38.8127454154
258O-linked_GlycosylationKAITEPVTVKMQLRR
CCCCCCEEEEEEECC
25.7327454154
267PhosphorylationKMQLRRPSDQEVSES
EEEECCCCCHHHHHH
50.5521082442
350 (in isoform 2)O-linked_Glycosylation-5.6227454154
359PhosphorylationGSIGEGRYFKKEPNL
CCCCCCCCCCCCCCC
30.5222817900
368PhosphorylationKKEPNLFSHDAVVRE
CCCCCCCCCCEEEEE
24.5128555341
378O-linked_GlycosylationAVVREMPTGVSSQAE
EEEEECCCCCCCCCH
49.2427454154
382O-linked_GlycosylationEMPTGVSSQAESYYP
ECCCCCCCCCHHCCC
30.8827454154
386PhosphorylationGVSSQAESYYPSPGP
CCCCCCHHCCCCCCC
32.74-
387PhosphorylationVSSQAESYYPSPGPI
CCCCCHHCCCCCCCC
15.76-
409O-linked_GlycosylationASMAPLPSSSWSSVA
CCCCCCCCCCCCCCC
44.6927454154
421MethylationSVAHPTPRSGNTNPL
CCCCCCCCCCCCCCC
60.72115386197
422PhosphorylationVAHPTPRSGNTNPLS
CCCCCCCCCCCCCCC
37.2828555341
425PhosphorylationPTPRSGNTNPLSSFS
CCCCCCCCCCCCCCC
41.5628555341
425O-linked_GlycosylationPTPRSGNTNPLSSFS
CCCCCCCCCCCCCCC
41.5627454154
429PhosphorylationSGNTNPLSSFSTRTL
CCCCCCCCCCCCCCC
30.5128857561
430PhosphorylationGNTNPLSSFSTRTLP
CCCCCCCCCCCCCCC
30.7928857561
433PhosphorylationNPLSSFSTRTLPSNS
CCCCCCCCCCCCCCC
26.18-
435PhosphorylationLSSFSTRTLPSNSQG
CCCCCCCCCCCCCCC
43.0128555341
438PhosphorylationFSTRTLPSNSQGIPP
CCCCCCCCCCCCCCC
52.8328555341
492PhosphorylationISDPNMLSNCSVNMM
CCCHHHHCCCEEEEE
25.6416585559
503PhosphorylationVNMMTTSSDSMGETD
EEEEECCCCCCCCCC
31.4510823840
516PhosphorylationTDNPRLLSMNLENPS
CCCCCEEEECCCCCC
15.3728348404
523PhosphorylationSMNLENPSCNSVLDP
EECCCCCCCCCCCCH
37.2016585559
526PhosphorylationLENPSCNSVLDPRDL
CCCCCCCCCCCHHHH
28.5216585559
557PhosphorylationSNTTVFVSQSDAFEG
CCCEEEECCHHHCCC
16.7122817900
597PhosphorylationGFVQDSQYSGIGSMQ
CCCCCCCCCCCCCCC
16.9022817900

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
267SPhosphorylationKinasePKA-Uniprot
516SPhosphorylationKinaseCHUKO15111
GPS
516SPhosphorylationKinaseIKBKBO14920
GPS
526SPhosphorylationKinaseCHUKO15111
GPS
526SPhosphorylationKinaseIKBKBO14920
GPS
557SPhosphorylationKinaseCHUKO15111
GPS
557SPhosphorylationKinaseIKBKBO14920
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of REL_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of REL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PP4C_HUMANPPP4Cphysical
9837938
M3K8_HUMANMAP3K8physical
14743216
PAPOA_HUMANPAPOLAphysical
14743216
TF65_HUMANRELAphysical
14743216
TNIP2_HUMANTNIP2physical
14743216
IKBE_HUMANNFKBIEphysical
8415639
TF65_HUMANRELAphysical
8139561
MTPN_HUMANMTPNphysical
11971907
TF65_HUMANRELAphysical
11967310
IKBE_HUMANNFKBIEphysical
10706725
IKBA_HUMANNFKBIAphysical
10706725
IKBB_HUMANNFKBIBphysical
10706725
CDK2_HUMANCDK2physical
9731206
CBP_HUMANCREBBPphysical
19948376
EP300_HUMANEP300physical
19948376
SOCS3_HUMANSOCS3physical
21451109
IKBA_HUMANNFKBIAphysical
8887627
IKBB_HUMANNFKBIBphysical
8887627
TM165_HUMANTMEM165physical
21988832
ANDR_HUMANARphysical
17011549
TF65_HUMANRELAphysical
25416956
SAT1_HUMANSAT1physical
25416956
ATX1_HUMANATXN1physical
25416956
SDCB1_HUMANSDCBPphysical
25416956
S6A12_HUMANSLC6A12physical
25416956
RECK_HUMANRECKphysical
25416956
NCK2_HUMANNCK2physical
25416956
HAT1_HUMANHAT1physical
25416956
CGBP1_HUMANCGGBP1physical
25416956
STK16_HUMANSTK16physical
25416956
EIF3A_HUMANEIF3Aphysical
25416956
EIF3D_HUMANEIF3Dphysical
25416956
IF4E2_HUMANEIF4E2physical
25416956
RBM39_HUMANRBM39physical
25416956
K0100_HUMANKIAA0100physical
25416956
EPMIP_HUMANEPM2AIP1physical
25416956
ACOT8_HUMANACOT8physical
25416956
CAF1A_HUMANCHAF1Aphysical
25416956
TSSC4_HUMANTSSC4physical
25416956
ARI2_HUMANARIH2physical
25416956
MD2L2_HUMANMAD2L2physical
25416956
GA45G_HUMANGADD45Gphysical
25416956
MO4L1_HUMANMORF4L1physical
25416956
EXOS8_HUMANEXOSC8physical
25416956
R3HD2_HUMANR3HDM2physical
25416956
SC31A_HUMANSEC31Aphysical
25416956
SZT2_HUMANSZT2physical
25416956
TNS2_HUMANTENC1physical
25416956
DAAM2_HUMANDAAM2physical
25416956
EMAL2_HUMANEML2physical
25416956
RPA1_HUMANPOLR1Aphysical
25416956
NDUF3_HUMANNDUFAF3physical
25416956
NECP1_HUMANNECAP1physical
25416956
I36RA_HUMANIL36RNphysical
25416956
OSTF1_HUMANOSTF1physical
25416956
HSPB7_HUMANHSPB7physical
25416956
RSP14_HUMANRSPH14physical
25416956
CPSF1_HUMANCPSF1physical
25416956
NDK7_HUMANNME7physical
25416956
OSGI1_HUMANOSGIN1physical
25416956
A1CF_HUMANA1CFphysical
25416956
NGN3_HUMANNEUROG3physical
25416956
EXOS1_HUMANEXOSC1physical
25416956
MEMO1_HUMANMEMO1physical
25416956
CHCH2_HUMANCHCHD2physical
25416956
DC1L1_HUMANDYNC1LI1physical
25416956
POP5_HUMANPOP5physical
25416956
CINP_HUMANCINPphysical
25416956
HDAC7_HUMANHDAC7physical
25416956
OAZ3_HUMANOAZ3physical
25416956
TPC2L_HUMANTRAPPC2Lphysical
25416956
UBS3A_HUMANUBASH3Aphysical
25416956
OTUD4_HUMANOTUD4physical
25416956
TTC19_HUMANTTC19physical
25416956
S41A3_HUMANSLC41A3physical
25416956
CA109_HUMANC1orf109physical
25416956
TXN4B_HUMANTXNL4Bphysical
25416956
MGN2_HUMANMAGOHBphysical
25416956
NAGK_HUMANNAGKphysical
25416956
ASAP3_HUMANASAP3physical
25416956
NXT2_HUMANNXT2physical
25416956
CABP5_HUMANCABP5physical
25416956
IF5A2_HUMANEIF5A2physical
25416956
PPL13_HUMANLGALS14physical
25416956
PLCD_HUMANAGPAT4physical
25416956
M3KCL_HUMANMAP3K7CLphysical
25416956
EXOS5_HUMANEXOSC5physical
25416956
PRD10_HUMANPRDM10physical
25416956
CNBP1_HUMANCTNNBIP1physical
25416956
COKA1_HUMANCOL20A1physical
25416956
RN213_HUMANRNF213physical
25416956
LSM2_HUMANLSM2physical
25416956
NGB_HUMANNGBphysical
25416956
DMRT3_HUMANDMRT3physical
25416956
TMM8A_HUMANTMEM8Aphysical
25416956
PARVG_HUMANPARVGphysical
25416956
UBE2Z_HUMANUBE2Zphysical
25416956
OTUB2_HUMANOTUB2physical
25416956
FND11_HUMANC20orf195physical
25416956
ATG9A_HUMANATG9Aphysical
25416956
CCNJL_HUMANCCNJLphysical
25416956
SNR25_HUMANSNRNP25physical
25416956
NOL9_HUMANNOL9physical
25416956
FAD1_HUMANFLAD1physical
25416956
TSSK3_HUMANTSSK3physical
25416956
RASF5_HUMANRASSF5physical
25416956
CK068_HUMANC11orf68physical
25416956
PKHN1_HUMANPLEKHN1physical
25416956
MIEN1_HUMANMIEN1physical
25416956
VPS25_HUMANVPS25physical
25416956
CEP19_HUMANCEP19physical
25416956
KRA94_HUMANKRTAP9-4physical
25416956
BMF_HUMANBMFphysical
25416956
S39AD_HUMANSLC39A13physical
25416956
ATPF2_HUMANATPAF2physical
25416956
ZN765_HUMANZNF765physical
25416956
RIPP1_HUMANRIPPLY1physical
25416956
EGLN3_HUMANEGLN3physical
25416956
EFHC1_HUMANEFHC1physical
25416956
KLH32_HUMANKLHL32physical
25416956
CIB3_HUMANCIB3physical
25416956
PIHD2_HUMANPIH1D2physical
25416956
RM10_HUMANMRPL10physical
25416956
NR2CA_HUMANNR2C2APphysical
25416956
KLH40_HUMANKLHL40physical
25416956
GLCTK_HUMANGLYCTKphysical
25416956
ZN572_HUMANZNF572physical
25416956
ZN417_HUMANZNF417physical
25416956
TSTD2_HUMANTSTD2physical
25416956
PATE1_HUMANPATE1physical
25416956
ZN550_HUMANZNF550physical
25416956
ZN564_HUMANZNF564physical
25416956
FUT11_HUMANFUT11physical
25416956
TT21A_HUMANTTC21Aphysical
25416956
CENPX_HUMANSTRA13physical
25416956
CI072_HUMANC9orf72physical
25416956
CPNE2_HUMANCPNE2physical
25416956
NEIL2_HUMANNEIL2physical
25416956
ZDH24_HUMANZDHHC24physical
25416956
NUD14_HUMANNUDT14physical
25416956
S14L4_HUMANSEC14L4physical
25416956
BARH2_HUMANBARHL2physical
25416956
RAB41_HUMANRAB41physical
25416956
TRI74_HUMANTRIM74physical
25416956
OCC1_HUMANC12orf75physical
25416956
EP300_HUMANEP300physical
24529102
IKBE_HUMANNFKBIEphysical
26186194
NFKB2_HUMANNFKB2physical
26186194
NFKB1_HUMANNFKB1physical
26186194
TF65_HUMANRELAphysical
26186194
RELB_HUMANRELBphysical
26186194
TSR3_HUMANTSR3physical
26186194
TNIP2_HUMANTNIP2physical
26186194
BIRC3_HUMANBIRC3physical
25565375
NFKB2_HUMANNFKB2physical
28514442
IKBE_HUMANNFKBIEphysical
28514442
TF65_HUMANRELAphysical
28514442
NFKB1_HUMANNFKB1physical
28514442
TNIP2_HUMANTNIP2physical
28514442
TSR3_HUMANTSR3physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of REL_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Tumor necrosis factor-alpha activation of NF-kappa B requires thephosphorylation of Ser-471 in the transactivation domain of c-Rel.";
Martin A.G., Fresno M.;
J. Biol. Chem. 275:24383-24391(2000).
Cited for: PHOSPHORYLATION AT SER-503.

TOP